137 related articles for article (PubMed ID: 2814231)
1. Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma.
Harmenberg U; Frödin JE; Ljungdahl-Stähle E; Mellstedt H; Wahren B; Stigbrand T
Tumour Biol; 1989; 10(5):225-31. PubMed ID: 2814231
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
[TBL] [Abstract][Full Text] [Related]
4. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.
Stigbrand T; Riklund K; Tholander B; Hirano K; Lalos O; Stendahl U
Eur J Gynaecol Oncol; 1990; 11(5):351-60. PubMed ID: 2097151
[TBL] [Abstract][Full Text] [Related]
5. Immunopathology of alkaline phosphatase isozymes in seminoma.
Yamamoto H; Uchibayashi T; Koshida K; Hirano K; Hisazumi H
Urol Int; 1993; 50(1):33-5. PubMed ID: 8434423
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers in mammary carcinoma. An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50.
Rasmuson T; Björk GR; Damber L; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Oncol; 1987; 26(4):261-7. PubMed ID: 3479987
[TBL] [Abstract][Full Text] [Related]
7. Patterns of seminoma tissue markers and deletions.
Yamamoto H; Rudén U; Ljungdahl-Ståhle E; Brehmer-Andersson E; Hirano K; Hisazumi H; Stigbrand T; Wahren B
Int J Cancer; 1987 Nov; 40(5):615-9. PubMed ID: 2445700
[TBL] [Abstract][Full Text] [Related]
8. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M
Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological significance of an isozyme tumor marker--PLAP.
Fishman WH
Clin Biochem; 1987 Dec; 20(6):387-92. PubMed ID: 3325192
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of carcinoma-associated antigen 494 in colorectal cancer tissue and in Patients' sera during metastatic disease.
Lindhorst E
Tumour Biol; 2000; 21(2):116-22. PubMed ID: 10686541
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of alkaline phosphatase isozymes in human colorectal adenocarcinomas.
Harmenberg U; Koha M; Makiya R; Koshida K; Brismar B; Stigbrand T; Wahren B
Tumour Biol; 1991; 12(4):237-48. PubMed ID: 1871513
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte alkaline phosphatase and carcinoembryonic antigen in colorectal cancer patients (usefulness in the assessment of the stage).
Walach N; Guterman A; Zaidman JL; Kaufman S; Scharf S
Oncology; 1991; 48(2):128-30. PubMed ID: 1997936
[TBL] [Abstract][Full Text] [Related]
13. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Radiol Oncol; 1983; 22(3):209-14. PubMed ID: 6312760
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Radiol Oncol; 1984; 23(1):27-32. PubMed ID: 6328884
[TBL] [Abstract][Full Text] [Related]
15. CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
Toftager-Larsen K; Hørding U; Dreisler A; Daugaard S; Lund B; Bock J; Lundvall F; Frederiksen K; Nørgaard-Pedersen B
Gynecol Obstet Invest; 1992; 33(3):177-82. PubMed ID: 1319386
[TBL] [Abstract][Full Text] [Related]
16. The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer.
Ward U; Primrose JN; Finan PJ; Perren TJ; Selby P; Purves DA; Cooper EH
Br J Cancer; 1993 May; 67(5):1132-5. PubMed ID: 8494712
[TBL] [Abstract][Full Text] [Related]
17. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma.
Vergote IB; Abeler VM; Børmer OP; Stigbrand T; Tropé C; Nustad K
Tumour Biol; 1992; 13(3):168-74. PubMed ID: 1626181
[TBL] [Abstract][Full Text] [Related]
18. Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.
Heinonen PK; Kallioniemi OP; Koivula T
Tumori; 1987 Jun; 73(3):301-2. PubMed ID: 3474819
[TBL] [Abstract][Full Text] [Related]
19. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assay.
Nozawa S; Udagawa Y; Ohkura H; Negishi Y; Akiya K; Inaba N; Takamizawa H; Kimura E; Terashima Y
Clin Chim Acta; 1990 Jan; 186(2):275-84. PubMed ID: 2178810
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobicity and lectin affinity of alkaline phosphatase isozymes in seminoma and normal testis.
Koshida K; Stigbrand T; Hisazumi H; Wahren B
Tumour Biol; 1989; 10(4):173-80. PubMed ID: 2781220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
